Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 18 - Number 14

Review Article


Review Article

Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis

, 18(14): 1598 - 1621

Rudra Vaghela*, Parthasarathi K. Kulkarni, Riyaz Ali M. Osmani, Rohit R. Bhosale and Naga Sravan Kumar Varma V


DOI: 10.2174/1389450117666160401124133



Review Article


Review Article

Hydrogen Sulfide and Inflammatory Joint Diseases

, 18(14): 1641 - 1652

Elena F. Burguera*, Rosa Meijide-Failde and Francisco J. Blanco*


DOI: 10.2174/1389450117666160829112824



Review Article

The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators

, 18(14): 1653 - 1663

Chiranjib Chakraborty, Seong Lin Teoh and Srijit Das*


DOI: 10.2174/1389450117666160527142321



Review Article




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

August-2021-ban

Related Journals

Related eBooks

eBooks Catalog